论文信息 - 1042ODurvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study - 字舞流文

1042ODurvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study

A. Jimeno | G. Melillo | N. Ready | R. Mesía | A. Algazi | J. Fayette | D. Zandberg | A. Jarkowski | J. Armstrong | N. Bouganim | P. Clement | J. Good | K. Asubonteng | T. Goswmi